Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
---|---|---|
2021-10 | Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies | Elkamhawy, A.; Paik, S.; Park, J.-H.; Kim, H.J.; Hassan, A.H.E.; Lee, K.; Park, K.D.; Roh, E.J. |
2021-10 | Highly potent, selective, and competitive indole-based MAO-B inhibitors protect PC12 cells against 6-hydroxydopamine-and rotenone-induced oxidative stress | Elsherbeny, M.H.; Kim, J.; Gouda, N.A.; Gotina, L.; Cho, J.; Pae, A.N.; Lee, K.; Park, K.D.; Elkamhawy, A.; Roh, E.J. |
1999-12 | I-123 labelled paclitaxel | Roh, E.J.; Park, Y.H.; Oh, C.R.; Song, C.E.; Oh, S.-J.; Choe, Y.S.; Kim, B.-T.; Chi, D.Y.; Kim, D. |